August 5, 2016
Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to support the United States Breastfeeding Committee’s (USBC) designation of August as National Breastfeeding Month. Avion applauds the efforts of the USBC and recognizes that not all women are able to breastfeed but for those women who can, there are many positive benefits for both mom and baby. As a show of its support, Avion has donated $500.00 to the USBC to help fund further research efforts.
This year’s National Breastfeeding Month theme focuses on the progress made since 2011 when the Surgeon General released a call to action to support breastfeeding (SGCTA). The USBC is commemorating the successes of the past five years and working to continue to increase the number of women who adopt healthy behaviors before becoming pregnant, throughout their pregnancy and that also include breastfeeding.
Prenate® Restore is Avion’s first and only prescription post-natal supplement designed for breastfeeding that includes probiotics. The 15 vitamins, minerals, and nutrients included in Prenate Restore are designed to restore mom’s reserves and support infant growth. The probiotics help support the gastrointestinal and immune health of both baby and mom. Prenate Restore also includes high levels of DHA (400 mg), vitamin D, folic acid, iron, and calcium.
“Avion’s is committed to support our community of moms and babies with prescription nutritional support that meets expert recommendation for pregnancy and breastfeeding” said Mike Sullivan, President. “Our mission is to develop products that deliver maximum benefits along the continuum of care in women’s lives. These products are driven by a desire to improve the lives of both moms and babies and Avion is also proud to support the mission of the USBC”.
Avion Pharmaceuticals, LLC is a specialty pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women’s Heath and Dermatology therapeutic areas. Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188. For more information about Prenate® Restore visit wwww.prenate.com.